| human | Q5 |
| P496 | ORCID iD | 0000-0002-4743-8187 |
| P69 | educated at | Pennsylvania State University | Q739627 |
| Louisiana State University | Q1521725 | ||
| P108 | employer | Vanderbilt University | Q29052 |
| University of Arkansas for Medical Sciences | Q941298 | ||
| P734 | family name | Miller | Q1605060 |
| Miller | Q1605060 | ||
| Miller | Q1605060 | ||
| P735 | given name | Grover | Q19731861 |
| Grover | Q19731861 | ||
| P106 | occupation | researcher | Q1650915 |
| Q47775339 | 1,3-Butadiene-induced mitochondrial dysfunction is correlated with mitochondrial CYP2E1 activity in Collaborative Cross mice. |
| Q91872649 | A Time-Embedding Network Models the Ontogeny of 23 Hepatic Drug Metabolizing Enzymes |
| Q81742835 | Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective |
| Q33644101 | Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans. |
| Q33759278 | Beta sheet 2-alpha helix C loop of cytochrome P450 reductase serves as a docking site for redox partners. |
| Q89315633 | Biotransformation and bioactivation reactions - 2017 literature highlights * |
| Q92566610 | Biotransformation and bioactivation reactions - 2018 literature highlights |
| Q92698406 | CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches |
| Q45119326 | CYP2E1 hydroxylation of aniline involves negative cooperativity. |
| Q36296191 | CYP2E1 metabolism of styrene involves allostery. |
| Q55246631 | CYP2E1 substrate inhibition. MECHANISTIC INTERPRETATION THROUGH AN EFFECTOR SITE FOR MONOCYCLIC COMPOUNDS. |
| Q41974588 | CYP2E1 substrate inhibition. Mechanistic interpretation through an effector site for monocyclic compounds |
| Q90667673 | Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation |
| Q47951975 | Computational Approach to Structural Alerts: Furans, Phenols, Nitroaromatics, and Thiophenes. |
| Q48199323 | Computationally Assessing the Bioactivation of Drugs by N-Dealkylation. |
| Q42976133 | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. |
| Q37692619 | Cooperative effects for CYP2E1 differ between styrene and its metabolites. |
| Q38979533 | Cooperativity in CYP2E1 metabolism of acetaminophen and styrene mixtures. |
| Q28661562 | Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites |
| Q44121796 | Diversity in the oxidation of substrates by cytochrome P450 2D6: lack of an obligatory role of aspartate 301-substrate electrostatic bonding. |
| Q36992700 | Global analysis of protein-protein interactions reveals multiple CYP2E1-reductase complexes. |
| Q33606800 | Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin |
| Q33614759 | Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin |
| Q28601142 | Inhibitory potency of 4-carbon alkanes and alkenes toward CYP2E1 activity |
| Q36479788 | Kynurenine Signaling Increases DNA Polymerase Kappa Expression and Promotes Genomic Instability in Glioblastoma Cells. |
| Q90750811 | Lamisil (terbinafine) toxicity: Determining pathways to bioactivation through computational and experimental approaches |
| Q37019459 | Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarins |
| Q38750476 | Microchannel plate detector detection efficiency to monoenergetic electrons between 3 and 28 keV. |
| Q40028855 | Modeling Epoxidation of Drug-like Molecules with a Deep Machine Learning Network. |
| Q37209287 | Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network. |
| Q27334876 | Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites. |
| Q97519417 | Novel advances in biotransformation and bioactivation research-2019 year in review |
| Q58544491 | Novel isomeric metabolite profiles correlate with warfarin metabolism phenotype during maintenance dosing in a pilot study of 29 patients |
| Q83797547 | Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma |
| Q44047581 | Oxidation of methoxyphenethylamines by cytochrome P450 2D6. Analysis of rate-limiting steps. |
| Q52654369 | Regioselectivity significantly impacts microsomal glucuronidation efficiency of R/S-6, 7-, and 8-hydroxywarfarin. |
| Q100942265 | Significance of Competing Metabolic Pathways for 5F-APINACA Based on Quantitative Kinetics |
| Q102388091 | Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics |
| Q41289680 | Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione. |
| Q54158178 | Stereospecific Metabolism of R- and S-Warfarin by Human Hepatic Cytosolic Reductases. |
| Q35039736 | Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations |
| Q36315589 | Subcellular localization of rat CYP2E1 impacts metabolic efficiency toward common substrates |
| Q36509173 | The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis. |
| Q36007017 | The role of ERp44 in maturation of serotonin transporter protein. |
| Q36876067 | Thermal inactivation of the reductase domain of cytochrome P450 BM3. |
| Q47909554 | Toxicological Implications of Mitochondrial Localization of CYP2E1. |
| Q43269707 | Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism |
Search more.